Enforcement Report - Week of May 21, 2025
21 May 2025 //
FDA
Enforcement Report - Week of May 14, 2025
14 May 2025 //
FDA
Sun Pharma is on FDA Import Alert List with Recent update
12 May 2025 //
FDA
Enforcement Report - Week of May 7, 2025.pdf
07 May 2025 //
FDA
Nana Barseghian Recieves Warning Letter
06 May 2025 //
FDA
Nectar Life Sciences Limited`s Fails EDQM inspection
05 May 2025 //
EMA
Enforcement Report - Week of April 30, 2025
30 Apr 2025 //
FDA
Beo Pharmaceuticals Receives FDA Warning Letter
29 Apr 2025 //
FDA
Dyno Manufacturing Receives FDA Warning Letter
29 Apr 2025 //
FDA
Cosco International Receives FDA Warning Letter
29 Apr 2025 //
FDA
Enforcement Report - Week of April 23, 2025
23 Apr 2025 //
FDA
Amneal Issues a Nationwide Recall of Ropivacaine HCl
18 Apr 2025 //
FDA
Enforcement Report - Week of April 16, 2025
16 Apr 2025 //
FDA
PMS4PMS Receives FDA Warning Letter
15 Apr 2025 //
FDA
Enforcement Report - Week of April 2, 2025
02 Apr 2025 //
FDA
FDA Issues Form 483 to Laboratorios Farmaceuticos Rovi
28 Mar 2025 //
FDA
FDA Issues Form 483 to Suzhou Suncadia Biopharma
28 Mar 2025 //
FDA
FDA Issues Form 483 to Palmetto Isotopes LLC
28 Mar 2025 //
FDA
FDA Issues Form 483 to SKNV
28 Mar 2025 //
FDA
FDA Issues Form 483 to Eagle Pharma Outsourcing LLC
28 Mar 2025 //
FDA
FDA Issues Form 483 to Revive Rx LLC
28 Mar 2025 //
FDA
Health Canada Issues Recalls of Mint Pharma`s Rosuvastatin
26 Mar 2025 //
HEALTH CANADA
Enforcement Report - Week of March 26, 2025
26 Mar 2025 //
FDA
Yangzhou Sion Receives FDA Warning Letter
25 Mar 2025 //
FDA
Hangzhou Glamcos Biotech Receives FDA Warning Letter
25 Mar 2025 //
FDA
FDA Issues Form 483 to Eli Lilly & Company
24 Mar 2025 //
FDA
FDA Issues Form 483 to UCB Pharma SA
24 Mar 2025 //
FDA
FDA Issues Form 483 to Bushu Pharmaceuticals
24 Mar 2025 //
FDA
Health Canada Issues Recalls of Sandoz`s Fesoterodine
21 Mar 2025 //
HEALTH CANADA
Health Canada Issues Recalls of Marcan Pharma`s Cetirizine
20 Mar 2025 //
HEALTH CANADA
Health Canada Issues Recalls of Sanis Health`s Cetirizine
20 Mar 2025 //
HEALTH CANADA
Tribal Medicinal is on FDA Import Alert List
20 Mar 2025 //
FDA
Emporio Doces Neropolis is on FDA Import Alert List
19 Mar 2025 //
FDA
Enforcement Report - Week of March 19, 2025
19 Mar 2025 //
FDA
Institut Georges Lopez`s Fails EDQM inspection
18 Mar 2025 //
EMA
Aspen Pharmacare Receives FDA Warning Letter
18 Mar 2025 //
FDA
Zacanta Receives FDA Warning Letter
18 Mar 2025 //
FDA
International Lab Receives FDA Warning Letter
18 Mar 2025 //
FDA
Vegewax Candleworx Receives FDA Warning Letter
18 Mar 2025 //
FDA
MG Infusions Receives FDA Warning Letter
18 Mar 2025 //
FDA
Advanced Pharmaceutical Receives FDA Warning Letter
18 Mar 2025 //
FDA
Aspen SA Sterile is on Health Canada Inspection List
18 Mar 2025 //
HEALTH CANADA
Genzyme Corporation is on Health Canada Inspection List
18 Mar 2025 //
HEALTH CANADA
Global Calcium is on Health Canada Inspection List
18 Mar 2025 //
HEALTH CANADA
Indoco Remedies Limited is on Health Canada Inspection List
18 Mar 2025 //
HEALTH CANADA
Jagsonpal Pharmaceuticals is on Health Canada Inspection List
18 Mar 2025 //
HEALTH CANADA
Mylan Labs is on Health Canada Inspection List
18 Mar 2025 //
HEALTH CANADA
Nectar Lifesciences is on Health Canada Inspection List
18 Mar 2025 //
HEALTH CANADA
Tyche Industries is on Health Canada Inspection List
18 Mar 2025 //
HEALTH CANADA
Yung Shin Pharma is on Health Canada Inspection List
18 Mar 2025 //
HEALTH CANADA
Dr. Reddy’s Issues a Nationwide Recall of Levetiracetam in NaCl Inj
13 Mar 2025 //
FDA
Enforcement Report - Week of March 12, 2025
12 Mar 2025 //
FDA
FDA Issues Form 483 to MedisourceRx
11 Mar 2025 //
FDA
Be Pharma`s Fails EDQM inspection
10 Mar 2025 //
EMA
FDA Issues Form 483 to Wuxi Biologics
06 Mar 2025 //
FDA
Enforcement Report - Week of March 5, 2025
05 Mar 2025 //
FDA
Health Canada Issues Recalls of Omega Lab`s Sodium Acetate
05 Mar 2025 //
HEALTH CANADA
TKTX Numbing Cream Receives FDA Warning Letter
04 Mar 2025 //
FDA
Chem-Tech Receives FDA Warning Letter
04 Mar 2025 //
FDA
Granules India Receives FDA Warning Letter
04 Mar 2025 //
FDA